MYELOFIBROSIS; ANEMIA
Clinical trials for MYELOFIBROSIS; ANEMIA explained in plain language.
Never miss a new study
Get alerted when new MYELOFIBROSIS; ANEMIA trials appear
Sign up with your email to follow new studies for MYELOFIBROSIS; ANEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug aims to free blood cancer patients from frequent transfusions
Disease control Recruiting nowThis study tests an experimental drug called DISC-0974 in about 150 adults with myelofibrosis or myelodysplastic syndrome who also have anemia. The goal is to see if the drug is safe and can help patients need fewer or no blood transfusions. The study is in early to mid stages an…
Matched conditions: MYELOFIBROSIS; ANEMIA
Phase: PHASE1, PHASE2 • Sponsor: Disc Medicine, Inc • Aim: Disease control
Last updated May 26, 2026 07:50 UTC
-
Old HIV drug may help bone marrow make red blood cells in rare cancer
Disease control Recruiting nowThis study tests whether Nelfinavir, a drug originally used for HIV, can improve anemia in people with myelofibrosis, a rare bone marrow cancer. The drug aims to help the body deliver iron to the bone marrow to make more red blood cells. About 10 adults with low hemoglobin will t…
Matched conditions: MYELOFIBROSIS; ANEMIA
Phase: PHASE1, PHASE2 • Sponsor: University of California, Irvine • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
New registry study aims to map Real-World care for myelofibrosis anemia
Knowledge-focused Recruiting nowThis study is a registry that will follow 200 people in Germany with myelofibrosis and anemia. It will collect information on which treatments are used, how well they work, and how patients feel. The goal is to better understand current care and outcomes, not to test a new drug.
Matched conditions: MYELOFIBROSIS; ANEMIA
Sponsor: iOMEDICO AG • Aim: Knowledge-focused
Last updated May 26, 2026 07:56 UTC